US2012165356A1PendingUtilityA1

Spirocyclic heterocyclic derivatives and methods of their use

58
Assignee: DOLLE ROLAND EPriority: Oct 1, 2003Filed: Oct 17, 2011Published: Jun 28, 2012
Est. expiryOct 1, 2023(expired)· nominal 20-yr term from priority
A61P 37/02A61P 41/00A61P 9/06A61P 9/00A61P 9/10A61P 37/06A61P 43/00A61P 37/08A61P 9/12A61P 25/24A61P 25/08A61P 25/28A61P 25/32A61P 27/06A61P 31/12A61P 25/00A61P 25/14A61P 25/22A61P 25/34A61P 25/16A61P 25/04A61P 25/36A61P 25/30A61P 31/04A61P 29/00A61P 25/18A61P 25/20A61P 11/00C07D 493/10C07D 311/96C07D 491/107A61P 13/02C07D 221/20A61P 1/00A61P 15/00A61P 23/00A61P 11/14C07D 495/10A61P 15/10C07D 401/04A61P 1/04A61P 19/02A61P 13/00A61P 17/06A61P 11/06A61P 15/12A61K 31/438C07D 491/10
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Spirocyclic heterocyclic derivatives, pharmaceutical compositions containing these compounds, and methods for their pharmaceutical use are disclosed. In certain embodiments, the spirocyclic heterocyclic derivatives are ligands of the δ opioid receptor and may be useful, inter alia, for treating and/or preventing pain, anxiety, gastrointestinal disorders, and other δ opioid receptor-mediated conditions.

Claims

exact text as granted — not AI-modified
1 - 148 . (canceled) 
     
     
         149 . A method for preventing or treating a urogenital tract disorder, comprising the step of:
 administering to a patient in need thereof an effective amount of a compound of the following formula:   
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt or N-oxide thereof. 
     
     
         150 . A method according to  claim 149 ,
 wherein said urogenital tract disorder is incontinence or overactive bladder.   
     
     
         151 . A method according to  claim 150 , wherein said incontinence is stress urinary incontinence or urge urinary incontinence. 
     
     
         152 . A method according to  claim 150 , wherein said urogenital tract disorder is overactive bladder. 
     
     
         153 . A method according to  claim 150  further comprising the step of:
 administering to said patient an effective amount of an agent for the treatment of incontinence.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.